Cell Genesys Announces Final Results from Phase 3 Program of GVAX Immunotherapy for Prostate Cancer HAYWARD, Calif.--(BUSINESS WIRE)--Cell Genesys, Inc. (NASDAQ:CEGE) announced today results from f

GTx begins clinical trials for androgen deprivation therapy Memphis Business Journal Volunteers are now receiving doses of GTx’s luteinizing hormone (LH) inhibitor, an androgen deprivation therapy

GTx initiates Phase I prostate cancer trial Published:26-February-2009 By Datamonitor staff writer GTx, a biopharmaceutical company, has initiated a Phase I clinical trial for GTx-758, an oral lu

Measles virus derivatives boon for prostate cancer Washington (IANS): Certain measles virus vaccine strain derivatives can effectively infect and kill prostate cancer cells. Prostate cancer is t

Molecular urine test detected aggressive prostate cancer 2009 Genitourinary Cancers Symposium Results from a prospective study have shown that a prototype molecular urine test accurately detected

NDA Accepted for Six-Month Prostate Cancer Treatment William WeberJanuary 22, 2009 Prostate Cancer The New Drug Application (NDA) by Watson Pharmaceuticals, Inc., for a six-month formulation of

Negative Findings Of Major Prostate Cancer Trial Support AICR Recommendation On Supplement Use Article Date: 13 Jan 2009 - 3:00 PST New data published in the January 7 issue of the Journal of th

Participation in clinical trials is critical to the approval cycle for new treatments. It is usually the only way a patient can gain access to the latest innovative therapies. While PCRI does not endo

January 20, 2009 Prostate Cancer Genetic Testing - Is it real or is it boutique lab work? Analysis of: Clarient Launches Gene Expression Test for Prostate Cancer (www.medcompare.com) This analysi

Selective Expression of CD44, a Putative Prostate Cancer Stem Cell Marker, in Neuroendocrine Tumor Cells of Human Prostate Cancer Friday, 27 February 2009 Department of Pathology, Un